Skip to main content

View full-text article in PMC

. 2020 Jul 23;10:12324. doi: 10.1038/s41598-020-69010-1

Table 2.

Treatment effects on the serum concentrations of IL-2 and IFN-γ.

Immune factors (ng/L)	Growth point (day)	Treatments
Immune factors (ng/L)	Growth point (day)	Control	L	M	H
IL-2	14	42.13 ± 2.32	44.2 ± 3.15	45.5 ± 2.11	44.4 ± 2.12
	28	45.43 ± 3.13^b	46.5 ± 4.21^b	55.4 ± 4.14^a	58.7 ± 3.11^a
	42	26.12 ± 3.14^b	32.2 ± 4.28^a	34.2 ± 1.50^a	31.1 ± 2.10^a
IFN-γ	14	11.21 ± 0.88	11.56 ± 0.56	12.01 ± 0.72	11.44 ± 0.91
	28	8.21 ± 0.65^b	9.82 ± 0.44^a	10.16 ± 0.57^a	9.72 ± 0.61^a
	42	5.63 ± 0.43^c	6.31 ± 0.45^bc	7.32 ± 0.41^a	6.84 ± 0.37^ab

^a–^cValues in the same row without the same uppercase differed significantly (P < 0.05).